Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5679b0dbe4c28b66dc9eae65408a8d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_390be8b40737dd62f57f366e17a9af5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_528ae3a1fbf368091c65e85e99965072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf2ac6dc66c1118be9e0ffa4d0967cfd |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55594 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
filingDate |
2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d7ea5aca3099183309d6321782ffcd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07c84154cb8a26b5c70ed4c4d1617044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a14ce3734b3970e9272e39f3906f813 |
publicationDate |
2003-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03065787-A2 |
titleOfInvention |
Methods and compositions for the targeting of a systemic immune response to specific organs or tissues |
abstract |
The invention provides methods and compositions for targeting a separately generated immune response to a specific organ or tissue; e.g. one affected by cancer, using one or more agents with a tropism for the organ or tissue r that can be specifically localized to the desired organ or tissue. For example, the invention provides methods and compositions for treating liver metastases from colorectal cancer using a combination of a granulocyte/macrophage colony stimulating factor (GM-CSF) augmented tumor cell vaccination and Listeria monocytogenes (LM) infection. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022125901-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130692-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11554185-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10799533-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11096963-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11235090-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7842289-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007022520-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007022511-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007022511-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007022520-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10086066-B2 |
priorityDate |
2002-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |